Cattinara Hospital
- Address
- Strada Di Fiume 447, 34149 Trieste, Italy
Respiratory Tract Diseases Research
At Cattinara Hospital in Trieste, clinical research in Respiratory Tract Diseases focuses on conditions such as bronchiectasis and pulmonary hypertension associated with chronic obstructive pulmonary disease. These studies are designed to assess whether new treatments can improve symptoms, support breathing capacity, and offer longer-term disease control.
- Studies in bronchiectasis are examining ongoing treatment options for people who have already taken part in earlier research.
- Research in PH-COPD is evaluating whether new therapies can improve exercise tolerance and overall lung-related outcomes.
- Safety is also a key focus, with investigators tracking treatment-related side effects alongside potential benefits.
This work reflects a strong interest in improving care for chronic respiratory conditions through better treatment effectiveness and patient safety.
Cardiovascular Diseases and Pulmonary Vascular Research
Clinical trials in the Cardiovascular Diseases area at this site are centered on heart failure with pulmonary hypertension due to left heart disease. The research is aimed at understanding whether new therapies can reduce vascular resistance, ease strain on the heart and lungs, and improve day-to-day functioning.
- One study is exploring treatment effects on pulmonary vascular resistance in people with heart failure and PH Group 2.
- Another trial is looking at whether therapy can improve walking ability and overall physical performance.
- These studies also monitor safety to determine how well the treatments are tolerated over time.
The Unidad Operativa di Pneumologia contributes to research that connects heart and lung health, with a clear focus on practical clinical benefit.
Immune System Diseases and Autoimmune Research
Research in Immune System Diseases at Cattinara Hospital includes studies in autoimmune disease, particularly lupus nephritis. The main goal is to evaluate whether new therapies can help control active disease while maintaining an acceptable safety profile.
- Trials are focused on lupus nephritis in patients with active kidney involvement linked to autoimmune disease.
- Investigators are assessing both treatment effectiveness and safety in people with more severe disease patterns.
- The research aims to improve disease control and support better long-term outcomes for patients.
This area highlights the site’s involvement in autoimmune research that seeks better options for complex inflammatory conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cattinara Hospital
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2a Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-5475 in Adults With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease. | Merck Sharp & Dohme LLC | Phase II | Not Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid | 1 | Unknown | 2023-03-01 | 2023-03-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.